Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
6.210
+0.320 (+5.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
September 30, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
September 28, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases
September 27, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
1 Recent Healthcare IPO to Put on Your Radar
September 24, 2021
Here's a pharmaceutical company that could have an incredibly bright future.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement. As p...
Via
Benzinga
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some “War on Drugs” Impacts
September 22, 2021
Via
FinancialNewsMedia
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
September 21, 2021
We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses.
Via
Talk Markets
Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
September 20, 2021
AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares
Via
Benzinga
Analyzing Compass Pathways's Unusual Options Activity
August 11, 2021
On Wednesday, shares of Compass Pathways (NASDAQ:CMPS) sa...
Via
Benzinga
Analyzing Compass Pathways's Unusual Options Activity
August 10, 2021
Shares of Compass Pathways (NASDAQ:CMPS) saw some unusual...
Via
Benzinga
Which Psychedelic Stock ETF Is Right For You?
September 18, 2021
This week the AdvisorShares Psychedelics ETF began trading on the NYSE Arca. Here we compare the make-up of the now 3 psychedelic stock ETFs and two tracking indexes.
Via
Talk Markets
Compass: Psychedelics Unicorn Expands Portfolio Beyond Psilocybin Into Psychedelics 2.0
September 15, 2021
Psychedelics biotech company Compass Pathways (NASDAQ:CMPS...
Via
Benzinga
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
National Suicide Prevention Week Shines Light on Psychedelic Treatments
September 09, 2021
Via
FinancialNewsMedia
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 08, 2021
Gainers Cardiff Oncology (NASDAQ:
Via
Benzinga
3 Biotech Stocks Wall Street Expects to Double Soon
September 07, 2021
All three stocks on this list can more than double your money according to investment bank analysts who cover them.
Via
The Motley Fool
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Magic Mushroom Drug Stock Performances YTD
August 29, 2021
Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”.
Via
Talk Markets
Braxia Scientific Launches Broad Criteria Trial On Psilocybin For Depression
August 27, 2021
Braxia Scientific Corp. (CSE:BRAX) (OTC:
Via
Benzinga
Open-Minded? Buy This Game-Changing Psychedelics Stock Now
August 26, 2021
Excellent investing opportunities frequently seem outlandish.
Via
The Motley Fool
Topics
Supply Chain
Exposures
Supply Chain
Psychedelic Drug Patents: All Patents Are Not Created Equal
August 20, 2021
With many drug patenting opportunities in the emerging psychedelic drug industry, investors need to get up-to-speed on the different types of patents available -- and their strengths and weaknesses.
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
3 Disruptive Mental Health Stocks to Consider Buying Before They're Huge
August 14, 2021
They're the first pioneers in exciting new markets.
Via
The Motley Fool
Compass Pathways Q2 Financials: Net Profit Down -38%; Stock Down -59% YTD
August 12, 2021
COMPASS Pathways plc reported its financial results for the Q2 ending June 30th, 2021, today, and gave an update on recent progress across its business.
Via
Talk Markets
Atai Life Sciences To Research Potent Psychedelic Herb Salvia Divinorum Through Its New Subsidiary
August 12, 2021
Atai Life Sciences (NASDAQ:ATAI) has announced the launch ...
Via
Benzinga
COMPASS Pathways plc (CMPS) Q2 2021 Earnings Call Transcript
August 11, 2021
CMPS earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know
August 05, 2021
Cybin (NYSE:CYBN), a biotech company in the psychedelics spa...
Via
Benzinga
Growing Psychedelic Interest Will Help Push Compass Pathways Stock Up 3X By 2022
August 04, 2021
Psychedelic stock headwinds are improving, and since Compass is at the forefront of psychedelic therapy, look for CMPS stock to take off soon.
Via
InvestorPlace
Another Psychedelic Stock Debuts, As This One Sets Up In A Base
July 29, 2021
Field Trip Health dipped in its first day on the Nasdaq, making it the latest psychedelics company to hit a big U.S. exchange.
Via
Investor's Business Daily
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
July 23, 2021
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday,
Via
Benzinga
< Previous
1
2
...
21
22
23
24
25
26
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.